These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 31776327
21. Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson's disease-like motor dysfunction. Suda Y, Kuzumaki N, Sone T, Narita M, Tanaka K, Hamada Y, Iwasawa C, Shibasaki M, Maekawa A, Matsuo M, Akamatsu W, Hattori N, Okano H, Narita M. Mol Brain; 2018 Feb 20; 11(1):6. PubMed ID: 29458391 [Abstract] [Full Text] [Related]
22. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model. Wegrzynowicz M, Bar-On D, Calo' L, Anichtchik O, Iovino M, Xia J, Ryazanov S, Leonov A, Giese A, Dalley JW, Griesinger C, Ashery U, Spillantini MG. Acta Neuropathol; 2019 Oct 20; 138(4):575-595. PubMed ID: 31165254 [Abstract] [Full Text] [Related]
23. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration. Jimenez-Ferrer I, Jewett M, Tontanahal A, Romero-Ramos M, Swanberg M. Neurobiol Dis; 2017 Oct 20; 106():279-290. PubMed ID: 28736195 [Abstract] [Full Text] [Related]
24. CRISPR/Cas9-mediated generation of a tyrosine hydroxylase reporter iPSC line for live imaging and isolation of dopaminergic neurons. Calatayud C, Carola G, Fernández-Carasa I, Valtorta M, Jiménez-Delgado S, Díaz M, Soriano-Fradera J, Cappelletti G, García-Sancho J, Raya Á, Consiglio A. Sci Rep; 2019 May 02; 9(1):6811. PubMed ID: 31048719 [Abstract] [Full Text] [Related]
25. CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons. Qing X, Walter J, Jarazo J, Arias-Fuenzalida J, Hillje AL, Schwamborn JC. Stem Cell Res; 2017 Oct 02; 24():44-50. PubMed ID: 28826027 [Abstract] [Full Text] [Related]
26. Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons. Bono F, Savoia P, Guglielmi A, Gennarelli M, Piovani G, Sigala S, Leo D, Espinoza S, Gainetdinov RR, Devoto P, Spano P, Missale C, Fiorentini C. Mol Neurobiol; 2018 Feb 02; 55(2):1054-1067. PubMed ID: 28092083 [Abstract] [Full Text] [Related]
28. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. Kirik D, Rosenblad C, Burger C, Lundberg C, Johansen TE, Muzyczka N, Mandel RJ, Björklund A. J Neurosci; 2002 Apr 01; 22(7):2780-91. PubMed ID: 11923443 [Abstract] [Full Text] [Related]
29. In-vitro analysis of Pitx3 in mesodiencephalic dopaminergic neuron maturation. Papanikolaou T, Amano T, Lennington J, Sink K, Farrar AM, Salamone J, Yang X, Conover JC. Eur J Neurosci; 2009 Jun 01; 29(12):2264-75. PubMed ID: 19508691 [Abstract] [Full Text] [Related]
30. Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer. Bono F, Mutti V, Savoia P, Barbon A, Bellucci A, Missale C, Fiorentini C. Neurobiol Dis; 2019 Sep 01; 129():1-12. PubMed ID: 31051233 [Abstract] [Full Text] [Related]
31. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease. Coune PG, Bensadoun JC, Aebischer P, Schneider BL. J Parkinsons Dis; 2011 Sep 01; 1(4):373-87. PubMed ID: 23939344 [Abstract] [Full Text] [Related]
32. Expression and role of nicotinic acetylcholine receptors during midbrain dopaminergic neuron differentiation from human induced pluripotent stem cells. Kato T, Nishimura K, Hirao M, Shimohama S, Takata K. Neuropsychopharmacol Rep; 2023 Sep 01; 43(3):440-445. PubMed ID: 37366076 [Abstract] [Full Text] [Related]
33. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H. J Neurochem; 2004 Oct 01; 91(2):451-61. PubMed ID: 15447678 [Abstract] [Full Text] [Related]